AMICUS THERAPEUTICS, INC. Marketable Securities (Current)
AMICUS THERAPEUTICS, INC. had Marketable Securities (Current) of $79.53 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-02-20
- 2025-12-31: Marketable Securities, Current $79.53M.
- 2025-09-30: Marketable Securities, Current $73.29M.
- 2025-06-30: Marketable Securities, Current $72.30M.
- 2025-03-31: Marketable Securities, Current $68.92M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-12-31 | $79.53M 10-K · filed 2026-02-20 |
| 2025-09-30 | $73.29M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $72.30M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $68.92M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $36.19M 10-K · filed 2026-02-20 |
| 2024-09-30 | $16.11M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $50.73M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $29.84M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $39.21M 10-K · filed 2025-02-19 |
| 2023-09-30 | $16.98M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $54.32M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $106.51M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $144.78M 10-K · filed 2024-02-28 |
| 2022-09-30 | $77.11M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $151.20M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $177.88M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $237.30M 10-K · filed 2023-03-01 |
| 2021-09-30 | $171.06M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $206.53M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $232.60M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $320.03M 10-K · filed 2022-02-24 |
| 2020-09-30 | $298.45M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $145.02M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $215.64M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $309.90M 10-K · filed 2021-03-01 |
| 2019-09-30 | $347.88M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $355.08M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $341.98M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $424.40M 10-K · filed 2020-03-02 |
| 2018-09-30 | $362.56M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $465.64M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $309.50M 10-K · filed 2019-02-28 |